Longitudinal Changes in Peripapillary Atrophy in the Ocular Hypertension Treatment Study: A Case-Control Assessment
Longitudinal measurement of peripapillary atrophy (PPA) size, particularly the ?-zone, is an unreliable means of diagnosing the conversion of ocular hypertension to glaucoma because PPA may enlarge to the same degree in converters and nonconverters.
Comparison of Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration According to LUCAS Treat-and-Extend Protocol
The treatment of neovascular age-related macular degeneration with bevacizumab or ranibizumab according to the treat-and-extend protocol showed equivalent improvement in visual acuity at 1-year follow-up. Fewer injections were needed with ranibizumab.
View the current issue of Ophthalmology.
The State of Generic Drugs
Rising prices and frequent shortages of nonproprietary drugs seem to be plaguing ophthalmology. A look at the forces at work behind this ongoing issue.
View the current issue of EyeNet.
Manage Your Subscriptions